The reduction in price target by RBC Capital may have a neutral to slightly negative impact on TransAlta's stock (TAC) in the short term as it suggests a lower valuation than previously estimated. However, the maintenance of an Outperform rating indicates that the analyst still sees the company as a good investment, which could mitigate any negative reaction.